1. Stocks
  2. Teva- Pharmaceutical Industries Ltd. - ADR
  3. Swot
swot-logo

Teva- Pharmaceutical Industries Ltd. - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Teva- Pharmaceutical Industries Ltd. - ADR has 6 Strengths, 14 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Increasing profits every quarter for the past 2 quarters

Top Gainers

Stock with Low PE (PE < = 10)

Momentum Trap (DVM)

Companies with High Debt

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Companies with Increasing Debt

Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)

Declining Net Cash Flow : Companies not able to generate net cash

Book Value Per Share deteriorating for last 2 years

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month